GlycoMimetics (GLYC) Misses Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to GlycoMimetics (GLYC) Misses Q4 EPS by 2c

GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2022

March 29, 2023 7:00 AM EDT

Significant progress in strengthening leadership, raising capital, and preparing for final results of the uproleselan Phase 3 study in relapsed/refractory (R/R) acute myeloid leukemia (AML) Interim utility analysis used high statistical threshold and resulted in independent Data Monitoring Committee (DMC) recommending trial continue to final survival events, projected to occur in the first half of 2024; DMC also expressed no safety concerns about the trial Cash and cash equivalents expected to fund current operations to year end 2024 Conference call and webcast today at 8:30 a.m. ET

ROCKVILLE, Md.--(BUSINESS... More